Release Date: 22/03/11 19:08 Summary: Annual Reports to shareholders for 2009 and 2010 Price Sensitive: No Download Document 1MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%